Hologic Expects 2010 Launch Of Tomosynthesis System After FDA Panel Delay
This article was originally published in The Gray Sheet
Executive Summary
Hologic is now forecasting a late 2010 launch of its Selenia Dimensions tomosynthesis three-dimensional mammography system, after recent discussions with FDA led the firm to back out of a planned June advisory panel review
You may also be interested in...
Hologic Selenia 3D Digital Mammography System Gets Panel Nod
FDA's Radiological Devices Advisory Panel unanimously endorsed safety and efficacy data on Hologic's Selenia Dimensions 3D three-dimensional digital mammography system for screening and diagnosis of breast cancer at a Sept. 24 meeting
Hologic Selenia 3D Digital Mammography System Gets Panel Nod
FDA's Radiological Devices Advisory Panel unanimously endorsed safety and efficacy data on Hologic's Selenia Dimensions 3D three-dimensional digital mammography system for screening and diagnosis of breast cancer at a Sept. 24 meeting
Hologic Sales Drop In Q1 Despite Signs Of Capital-Equipment Market Recovery
Women's health firm Hologic reported a 10% decline in its breast health unit quarterly sales compared to last year on Feb. 1, but a 2.5% sequential increase from the prior quarter, indicating that the market for large capital equipment may be stabilizing, the firm said